Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.
- Conditions
- Rheumatoid Arthritis
- Registration Number
- NCT00034203
- Lead Sponsor
- XOMA (US) LLC
- Brief Summary
The purpose of this study is to determine whether a humanized monoclonal antibody (efalizumab) is safe and effective in the treatment of rheumatoid arthritis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (48)
University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States
Rheumatology Associates of North Alabama
🇺🇸Huntsville, Alabama, United States
Arizona Arthritis Research, PLC
🇺🇸Paradise Valley, Arizona, United States
Advanced Clinical Therapeutics, LLC
🇺🇸Tucson, Arizona, United States
NEA Clinic
🇺🇸Jonesboro, Arkansas, United States
Little Rock Diagnostic Clinic
🇺🇸Little Rock, Arkansas, United States
University of California at San Diego
🇺🇸La Jolla, California, United States
UCLA
🇺🇸Los Angeles, California, United States
Wallace Rheumatic Study Center
🇺🇸Los Angeles, California, United States
Boling Clinical Trials
🇺🇸Rancho Cucamonga, California, United States
Scroll for more (38 remaining)University of Alabama at Birmingham🇺🇸Birmingham, Alabama, United States